Modeling human disease in rodents by CRISPR/Cas9 genome editing

被引：0
|
作者：
Marie-Christine Birling
Yann Herault
Guillaume Pavlovic
机构：
[1] University of Strasbourg,CELPHEDIA, PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM
[2] Université de Strasbourg,Institut de Génétique et de Biologie Moléculaire et Cellulaire
[3] Centre National de la Recherche Scientifique,undefined
[4] Institut National de la Santé et de la Recherche Médicale,undefined
[5] Université de Strasbourg,undefined
来源：
Mammalian Genome | 2017年 / 28卷
关键词：
Genome Editing; International Mouse Phenotyping Consortium (IMPC); Non-allelic Homologous Recombination (NAHR); Low Copy Repeats (LCRs); Copy Number Variation (CNVs);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Modeling human disease has proven to be a challenge for the scientific community. For years, generating an animal model was complicated and restricted to very few species. With the rise of CRISPR/Cas9, it is now possible to generate more or less any animal model. In this review, we will show how this technology is and will change our way to obtain relevant disease animal models and how it should impact human health.
引用
收藏
页码：291 / 301
页数：10
相关论文
共 50 条
  • [31] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [32] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [34] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [35] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [36] Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
    Zarei, Ali
    Razban, Vahid
    Hosseini, Seyed Ebrahim
    Tabei, Seyed Mohammad Bagher
    JOURNAL OF GENE MEDICINE, 2019, 21 (04):
  • [37] CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?
    Feelixge, Harshana S. De Silva
    Stone, Daniel
    Roychoudhury, Pavitra
    Aubert, Martine
    Jerome, Keith R.
    ACS INFECTIOUS DISEASES, 2018, 4 (06): : 871 - 880
  • [38] Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
    Jarrett, Kelsey E.
    Lee, Ciaran M.
    Yeh, Yi-Hsien
    Hsu, Rachel H.
    Gupta, Rajat
    Zhang, Min
    Rodriguez, Perla J.
    Lee, Chang Seok
    Gillard, Baiba K.
    Bissig, Karl-Dimiter
    Pownall, Henry J.
    Martin, James F.
    Bao, Gang
    Lagor, William R.
    SCIENTIFIC REPORTS, 2017, 7
  • [39] Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
    Kelsey E. Jarrett
    Ciaran M. Lee
    Yi-Hsien Yeh
    Rachel H. Hsu
    Rajat Gupta
    Min Zhang
    Perla J. Rodriguez
    Chang Seok Lee
    Baiba K. Gillard
    Karl-Dimiter Bissig
    Henry J. Pownall
    James F. Martin
    Gang Bao
    William R. Lagor
    Scientific Reports, 7
  • [40] Therapeutic Crispr/Cas9 Genome Editing for Treating Sickle Cell Disease
    Park, So Hyun
    Lee, Ciaran M.
    Deshmukh, Harshavardhan
    Bao, Gang
    BLOOD, 2016, 128 (22)
12345